Reliable Business Intelligence News About Clinical Laboratories, Pathology Groups, & Laboratory
Diagnostics Since 1995

Subscriber?

Issues Archive

The most complete archive of clinical and pathology lab industry news available, including issues from 1997 to the present.

Volume XXX, Number 17 – December 4, 2023

In this issue:

In this issue, The Dark Report discusses the impact of artificial intelligence-powered solutions. The Dark Report suggests that it is timely for lab managers at all levels of the organization to begin learning about the field of artificial intelligence. In addition to this topic, discover how labs should be prepared for data to dominate diagnostics, understand that CLIA lab directors must monitor delegated duties, and stay informed about the latest regulatory and IVD updates.

View Issue TOC


Volume XXX, Number 16 – November 13, 2023

In this issue:

In this issue, Clinisys CEO Michael Simpson explains new developments in digital technologies that will expand the value and role of lab test data. Also, recent cases of healthcare fraud are examined, and whole genome sequencing for newborns is shown to be gaining favor with physicians and payers alike.

View Issue TOC


Volume XXX, Number 15 – October 23, 2023

In this issue:

This issue explores the financial difficulties of many hospitals and retail pharmacy chains, and also the problems that clinical laboratories have with proficiency testing. In addition, the Clinisys CEO discusses strategic changes that labs need to make.

View Issue TOC


Volume XXX, No. 14 – October 2, 2023

In this issue:

In the Oct. 2, 2023, issue of The Dark Report, we look at the Food and Drug Administration’s reasoning behind a proposed rule to more strictly regulate laboratory-developed tests. Other stories outline how the SALSA bill aims to combat PAMA cuts and what steps a clinical lab took to bring outreach services back in house.

View Issue TOC


Volume XXX, No. 13 – September 11, 2023

In this issue:

Recent court rulings involving the No Surprises Act are putting the government on the defensive about provisions of the law. Also, the continued consolidation of the IVD and national laboratory company markets has brought more influence to those lab companies. In addition, learn how clinical labs can earn money from their diagnostic data by helping private insurers navigate Medicare Advantage’s risk adjustment model.

View Issue TOC


Volume XXX, No. 12 – August 21, 2023

In this issue:

An industry expert outlines steps pathologists can take to protect their incomes from outside pressures. Also, self-insured companies and unions are suing payers over price transparency. In addition, guerrilla Kaizen events are described in detail to control lab waste and inefficiencies.

View Issue TOC


Volume XXX, No. 11 – July 31, 2023

In this issue:

This issue reports that one particular CPT billing code, once dubbed “fraudomatic” by an expert, is responsible for almost $1 billion in “improper” payments. Also, the architect of a one-year digital pathology rollout explains the steps his organization took in achieving this accomplishment.

View Issue TOC


Volume XXX, No. 10 – July 10, 2023

In this issue:

This issue of The Dark Report continues our coverage of new Z-code mandates for genetic tests, including an in-depth look at technical assessments that may be required. Also, Dartmouth Health explains innovative ways it developed to recruit and retain CLSs, and potential LDT regulation is again gaining steam.

View Issue TOC


Volume XXX, No. 9 – June 19, 2023

In this issue:

This issue examines the growing need for labs to present data to justify a genetic test earlier in processing of the claim. It also appears that more insurers will start requiring Z-codes for reimbursement of such tests, as UnitedHealthcare now does. In other news, a large laboratory system offers lessons learned on its rollout of the Epic Beaker LIS.

View Issue TOC


Volume XXX, No. 8 – May 30, 2023

In this issue:

Much lies underneath the surface of UnitedHealthcare’s (UHC) new policy mandating Z-code use for molecular tests covered under its commercial health plans. This development, which creates headaches for many genetic testing companies, is analyzed in depth here. Also, one company shows how data analytics improves lab productivity and TAT.

View Issue TOC


Don’t Be at the Mercy of the Tumultuous Healthcare Revolution

Subscribe to The Dark Report for as little as $15.27 per week.

platinum_edition

Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.

CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025

In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Start My 14 Day Trial
Learn More

Need A Group Membership? Company Discounts are Available!

Get More Information Now!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Click Here to Sign Up

Topics

Visit The Dark Library
Facebook-f Twitter Linkedin-in

The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com

© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group

;